ORIGINAL ARTICLES
Audit of the safety and effectiveness of ketamine for procedural sedation in the emergency department
1 Department of Emergency Medicine, Hairmyres Hospital, East Kilbride, UK
2 Department of Emergency Medicine, Glasgow Royal Infirmary, Glasgow, UK
3 Department of Emergency Medicine, Crosshouse Hospital, Kilmarnock, UK
4 Department of Emergency Medicine, Royal Free Hospital, London, UK
Correspondence to:
Miss J M Vardy, Department of Emergency Medicine, Hairmyres Hospital, East Kilbride G75 8RG, UK; jenvardy{at}doctors.net.uk
Aim: To examine the effectiveness and safety of the sedative agents used in the emergency department following the introduction of ketamine as an agent for procedural sedation
Methods: A 2-year prospective audit of sedation practice was undertaken. This specifically examined the rationale behind a doctors choice of sedative agent, the depth of sedation achieved, adverse events and the time taken to regain full orientation.
Results: 210 patients were included of whom 85 (40%) were given ketamine, 107 (51%) midazolam and 18 (9%) propofol. The median time to full orientation was 25 min for ketamine, 30 min for midazolam and 10 min for propofol. Complications occurred in 15.9% of sedations overall (14.6% of those given ketamine, 15.8% given midazolam and 22.2% given propofol). Apnoea and hypoxia most often occurred with midazolam and propofol, while hypertension and hypertonicity were encountered more frequently with ketamine. In addition, 19.5% of patients given ketamine suffered the re-emergence phenomenon. The association between deep sedation with no response to pain and adverse events encountered with midazolam does not occur with ketamine.
Conclusions: Ketamine is both safe and effective and compares favourably with midazolam as an agent for procedural sedation in the emergency department. Although the re-emergence phenomenon occurred, no psychological sequelae were encountered after return to full orientation. Ketamine may be particularly useful in groups of patients at high risk of adverse effects with midazolam.
Relevant Article
- Primary survey
- Malcolm Woollard
Emerg. Med. J. 2008 25: 545.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
-
Sibbald, N M, Jackson, M J, Howie, L A
(2009). How deep is your sedation?. Emerg. Med. J.
26: 389-389
[Full Text]
eLetters:
Read all eLetters
- How Deep Is Your Sedation?
- Natalie M Sibbald, et al.
- EMJ Online, 4 Nov 2008 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
